Nov 30, 2016 13:00 pm UTC| Business
ROMAINVILLE, France, Nov. 30, 2016 -- BIOPHYTIS (Alternext Paris:ALBPS), a biotechnology company specialized in the development of drug candidates to treat aging diseases, announces the successful completion of its...
Viracta acquires Phase 2 epigenetic drug candidate from Chroma Therapeutics
Nov 30, 2016 13:00 pm UTC| Business
SAN DIEGO and LONDON, Nov. 30, 2016 -- Viracta Therapeutics, Inc. announced completion of its acquisition of drug development candidate, VRx-3996, from Chroma Therapeutics, Ltd. Viracta plans to advance VRx-3996...
Nov 30, 2016 13:00 pm UTC| Business
PARIS and TOULOUSE, France, Nov. 30, 2016 -- Genticel (Euronext Paris Brussels: FR00011790542 – GTCL), a clinical-stage biotechnology company and developer of innovative immunotherapies, today announced that a...
Nov 30, 2016 12:32 pm UTC| Business
VANCOUVER, British Columbia, Nov. 30, 2016 -- Pure Energy Minerals Limited (TSX VENTURE:PE) (FRANKFURT:A111EG) (OTCQB:PEMIF) (the “Company” or “Pure Energy”) is pleased to announce that it has commenced drilling its...
Nov 30, 2016 12:30 pm UTC| Business
CARMIEL, Israel, Nov. 30, 2016 -- Protalix BioTherapeutics, Inc. (NYSE MKT:PLX) (TASE:PLX), announced today that the first patient has been enrolled in its phase II clinical trial of OPRX-106 for the treatment of...
Match-Trade introduces Ultra-fast Data Feed for FX Brokers
Nov 30, 2016 12:30 pm UTC| Business
Irvine, California, Nov. 30, 2016 -- Match-Trade Technologies LLC, ("Match-Trade" or the "Company"), headquartered in Irvine, California, is pleased to announce the launch of a new service for forex brokers known as the...
Nov 30, 2016 12:30 pm UTC| Business
PHILADELPHIA, Nov. 30, 2016 -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today that Katherine High, M.D.,...